GL1X · GenesisL1 explorer

Ligand · GAR

GAR · Glycinamide ribonucleotide

GAR, Glycinamide ribonucleotide (C7 H13 N2 O8 P -2, 284.2 g/mol), in the MolNFT structures on GenesisL1: bound in 9 records (8 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands…

Component
GAR
Formula
C7 H13 N2 O8 P -2
Class
ligand
Structures
9
PDB entries
8

Binding sites

GAR in 9 structures; the first of them:

  • 4ZYT · Human GAR transformylase in complex with GAR and… · GAR A1101 · binds GLY816, THR817, GLY818, SER819, ASN820, ALA893, GLY894, MET896 and 7 more
  • 4ZZ0 · Human GAR transformylase in complex with GAR and… · GAR A1101 · binds GLY816, THR817, GLY818, SER819, ASN820, ALA893, GLY894, MET896 and 7 more
  • 5J9F · Human GAR transformylase in complex with GAR and… · GAR A1101 · binds GLY816, THR817, GLY818, SER819, ASN820, ALA893, GLY894, MET896 and 7 more
  • 7JG0 · Human GAR transformylase in complex with GAR substrate and AGF102 inhibitor · GAR A1101 · binds GLY815, THR816, GLY817, SER818, ASN819, ALA892, GLY893, MET895 and 7 more
  • 8FJW · Human GAR transformylase in complex with GAR substrate and AGF347 inhibitor · GAR A1101 · binds GLY816, THR817, GLY818, SER819, ASN820, LEU821, ALA893, GLY894 and 8 more
  • 8FJX · Human GAR transformylase in complex with GAR substrate and AGF320 inhibitor · GAR A1102 · binds THR817, GLY818, SER819, ASN820, GLY894, MET896, ILE914, PRO916 and 2 more
  • 7JG0 · Human gar transformylase in complex with gar substrate and AGF102 inhibitor · GAR A1101 · binds THR816, GLY817, SER818, ASN819, GLY893, MET895, ILE913, HIS914 and 4 more
  • 7JG3 · Human gar transformylase in complex with gar substrate and AGF103 inhibitor · GAR A1101 · binds THR817, GLY818, SER819, ASN820, GLY894, MET896, ILE914, HIS915 and 4 more
  • 7JG4 · Human gar transformylase in complex with gar substrate and AGF131 inhibitor · GAR A1101 · binds THR817, GLY818, SER819, ASN820, GLY894, MET896, ILE914, HIS915 and 4 more

Residues it binds most

GLY 9, SER 9, ASN 9, GLU 9, ILE 9, LYS 9, MET 9, PRO 9, THR 9, HIS 8 (residue and the binding sites it lines).

Found with

  • V97 · N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]thiophene-2-carbonyl}-L-glutamic acid
  • NA · Sodium ion
  • 3Y9 · N-{4-[4-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoyl}-L-glutamic acid
  • 3YE · (S)-2-(8-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)octanamido)pentanedioic acid
  • 83A · N-(4-{[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)ethyl]amino}benzene-1-carbonyl)-L-glutamic acid
  • V9A · N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]furan-2-carbonyl}-L-glutamic acid
  • V9V · N-(5-{3-[(1S,7R,8R,9S)-4-amino-2-oxo-7lambda~4~-thia-3, 5-diazatetracyclo[4.3.0.0~1,7~.0~7,9~]nona-3,5-dien-8-yl]propyl}thiophene-2-carbonyl)-L-glutamic acid
  • Y79 · N-{4-[4-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)butyl]-2-fluorobenzoyl}-L-glutamic acid
  • Y7L · N-{5-[5-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)pentyl]thiophene-2-carbonyl}-L-glutamic acid

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.